Incyte | INCY - Stock

Stock Price
106.94
Daily Change
4.18 4.07%
Monthly
-3.28%
Yearly
44.26%
Q1 Forecast
96.99

Incyte reported $83.45M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Exelixis USD 27.4M 3.92M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Incyte USD 83.45M 24K Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
MacroGenics USD 8.75M 530K Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025